Bausch Health (BHC) EVP awarded 137,922 performance-based shares

Rhea-AI Filing Summary

Bausch Health Companies EVP and General Counsel Seana Carson reported an acquisition of 137,922 common shares on February 9, 2026 through a performance-based equity award. These shares relate to performance-based restricted share units originally granted on March 2, 2023.

On February 9, 2026, the Talent and Compensation Committee certified financial performance metrics for the period from January 1, 2023 through December 31, 2025, causing the PSUs to be earned. The units remain subject to service-based vesting through March 2, 2026, after which the company will deliver the earned common shares, bringing Carson’s direct beneficial ownership to 637,507 shares.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Carson Seana

(Last) (First) (Middle)

400 SOMERSET CORPORATE BOULEVARD

(Street)

BRIDGEWATER NJ 08807

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Bausch Health Companies Inc. [ BHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, General Counsel

3. Date of Earliest Transaction (Month/Day/Year)
02/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares, No Par Value	02/09/2026		A		137,922(1)	A	$0	637,507	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects performance-based restricted share units ("PSUs"), originally granted to the Reporting Person on March 2, 2023, which were earned, on February 9, 2026, upon certification by the Talent and Compensation Committee of the Board of Directors of the Issuer of the level of achievement of the financial performance metrics applicable to the PSUs for the performance period from January 1, 2023 through December 31, 2025. The PSUs remain subject to a service-based vesting condition through March 2, 2026. Subject to the satisfaction by the Reporting Person of the service-based vesting condition, the Issuer will deliver to the Reporting Person the number of Common Shares earned based on achievement of the financial performance metrics as soon as administratively practicable thereafter.

	/s/ Brianna M. Dorsi attorney-in-fact	02/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Bausch Health (BHC) report for Seana Carson?

Bausch Health reported that EVP and General Counsel Seana Carson acquired 137,922 common shares via a performance-based equity award. The award reflects performance-based restricted share units earned for 2023-2025 financial metrics and increases her direct beneficial ownership to 637,507 common shares.

When were Seana Carson’s performance-based PSUs at Bausch Health earned?

The performance-based restricted share units were earned on February 9, 2026. On that date, Bausch Health’s Talent and Compensation Committee certified the level of achievement of financial performance metrics for the period from January 1, 2023 through December 31, 2025 applicable to the PSUs.

What conditions still apply to Seana Carson’s Bausch Health share award?

The PSUs remain subject to a service-based vesting condition through March 2, 2026. Only if Seana Carson satisfies this continued service requirement will Bausch Health deliver the earned common shares, as soon as administratively practicable after the vesting date.

How many Bausch Health shares does Seana Carson own after this Form 4 transaction?

Following the reported transaction, Seana Carson beneficially owns 637,507 Bausch Health common shares directly. This figure reflects the acquisition of 137,922 shares associated with performance-based restricted share units earned based on financial metrics for the 2023-2025 performance period.

What was the reported price for Seana Carson’s 137,922 Bausch Health shares?

The 137,922 Bausch Health common shares were reported at a price of $0.00 per share. This reflects that the transaction was a grant or award acquisition of shares tied to previously granted performance-based restricted share units, rather than an open-market purchase.

What performance period covered the PSUs reported in Seana Carson’s Bausch Health Form 4?

The PSUs covered a performance period from January 1, 2023 through December 31, 2025. Financial performance metrics over this three-year span determined how many performance-based restricted share units were earned and converted into the right to receive common shares.